{"disease":{"id":"cisplatin","name":"cisplatin"},"drugs":{"marketed":[{"drug_id":"pemetrexed-disodium","indication_name":"Locally Advanced or Metastatic Non-Squamous NSCLC - Initial Treatment with Cisplatin","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PEMETREXED DISODIUM","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":35,"revenue":null,"mechanism":null},{"drug_id":"pemetrexed-disodium","indication_name":"Malignant Pleural Mesothelioma - Initial Treatment with Cisplatin","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PEMETREXED DISODIUM","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":35,"revenue":null,"mechanism":null},{"drug_id":"sodium-thiosulfate","indication_name":"Reduce the risk of ototoxicity associated with cisplatin","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sodium Thiosulfate","generic_name":"SODIUM THIOSULFATE","company_name":"Us Army","drug_phase":"marketed","molecular_target":"cytochrome a3, rhodanese","drug_class":"sodium thiosulfate","quality_score":65,"revenue":null,"mechanism":"Sodium nitrite forms methemoglobin to bind cyanide, while sodium thiosulfate donates sulfur for cyanide conversion to thiocyanate."}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03919552","title":"Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":482,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT06960577","title":"Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT03079427","title":"Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":101,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT07281508","title":"Transtympanic STS Against Cisplatin-induced SNHL: the SOUND Trial","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"The Netherlands Cancer Institute","has_results":false},{"nct_id":"NCT05586009","title":"Comparative Study of Different Doses of Magnesium as a Protective Agent in Nephrotoxicity in Cancer Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Tanta University","has_results":false},{"nct_id":"NCT05640817","title":"Nephroprotective Effect of Pentoxifylline Against Cisplatin in Patients With Head and Neck Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Tanta University","has_results":false},{"nct_id":"NCT05247671","title":"Evaluation of the Effect of Genetic Polymorphisms in ERCC1 and OCT2 on the Occurrence and Severity of Cisplatin-induced Nephrotoxicity","phase":"","overall_status":"UNKNOWN","enrollment_count":89,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT05244577","title":"Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":75,"lead_sponsor_name":"Shi Yanxia","has_results":false},{"nct_id":"NCT03373019","title":"Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":63,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT06297369","title":"Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT05030077","title":"Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":53,"lead_sponsor_name":"Tianjin Medical University Second Hospital","has_results":false},{"nct_id":"NCT02099786","title":"Randomized Trial Comparison of Ototoxicity Monitoring Programs","phase":"NA","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT07018622","title":"Protecting the Kidney's Proximal Tubules From Platinum-Based Chemotherapy Toxicity","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":46,"lead_sponsor_name":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","has_results":false},{"nct_id":"NCT07364747","title":"Protective Effect of Acetylcysteine Against Cisplatinum-Induced Ototoxicity: A Randomized Controlled Trial","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Siriraj Hospital","has_results":false},{"nct_id":"NCT05667415","title":"Treatment of Advance Gastric Cancer With Disulfiram","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"First People's Hospital of Hangzhou","has_results":false},{"nct_id":"NCT06521190","title":"ACOU085 for Hearing Loss Prevention in Testicular Cancer Patients Receiving Cisplatin","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Acousia Therapeutics GmbH","has_results":false},{"nct_id":"NCT05611307","title":"Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors","phase":"","overall_status":"TERMINATED","enrollment_count":31,"lead_sponsor_name":"Indiana University","has_results":false},{"nct_id":"NCT04848454","title":"Efficacy and Safety of Combinition of Camrelizumab in Second-line Neoadjuvant Chemotherapy and Adjuvant Therapy","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT03639168","title":"Chidamide Combined With Cisplatin in Head and Neck Adenoid Cystic Carcinoma (HNACC)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT04672330","title":"Neoadjuvant PD-1 Monoclonal Antibody in Cisplatin-ineligible High Risk Upper Tract Urothelial Carcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT02997189","title":"Study of OTO-104 in Subjects at Risk From Cisplatin-Induced Hearing Loss","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"Otonomy, Inc.","has_results":false},{"nct_id":"NCT04132882","title":"A Compassionate Use Program to Provide Access to Sodium Thiosulfate","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"TRPHARM","has_results":false}],"total":22},"guidelines":[],"source":"Drug Landscape verified database"}